Tesamorelin
Pharmaceutical drug
Tesamorelin
Tesamorelin (INN; trade names Egrifta, Egrifta SV and Egrifta WR) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy, approved initially in 2010. It is produced and developed by Theratechnologies, Inc. of Canada. The drug is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group.
Read on Wikipedia · Image Vaccinationist, Public domain
Open boosters, collect cards and trade them. Free to play.
Play for free